Copyright Reports & Markets. All rights reserved.

Global Ketorolac Injection Market Research Report 2021

Request for Sample of this report
Buy now

1 Ketorolac Injection Market Overview

  • 1.1 Product Overview and Scope of Ketorolac Injection
  • 1.2 Ketorolac Injection Segment by Type
    • 1.2.1 Global Ketorolac Injection Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 15mg/ml
    • 1.2.3 30mg/ml
  • 1.3 Ketorolac Injection Segment by Application
    • 1.3.1 Ketorolac Injection Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinics
    • 1.3.4 Recovery Center
  • 1.4 Global Ketorolac Injection Market Size Estimates and Forecasts
    • 1.4.1 Global Ketorolac Injection Revenue 2016-2027
    • 1.4.2 Global Ketorolac Injection Sales 2016-2027
    • 1.4.3 Ketorolac Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Ketorolac Injection Market Competition by Manufacturers

  • 2.1 Global Ketorolac Injection Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Ketorolac Injection Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Ketorolac Injection Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Ketorolac Injection Manufacturing Sites, Area Served, Product Type
  • 2.5 Ketorolac Injection Market Competitive Situation and Trends
    • 2.5.1 Ketorolac Injection Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Ketorolac Injection Players Market Share by Revenue
    • 2.5.3 Global Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ketorolac Injection Retrospective Market Scenario by Region

  • 3.1 Global Ketorolac Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Ketorolac Injection Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Ketorolac Injection Market Facts & Figures by Country
    • 3.3.1 North America Ketorolac Injection Sales by Country
    • 3.3.2 North America Ketorolac Injection Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Ketorolac Injection Market Facts & Figures by Country
    • 3.4.1 Europe Ketorolac Injection Sales by Country
    • 3.4.2 Europe Ketorolac Injection Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Ketorolac Injection Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Ketorolac Injection Sales by Region
    • 3.5.2 Asia Pacific Ketorolac Injection Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Ketorolac Injection Market Facts & Figures by Country
    • 3.6.1 Latin America Ketorolac Injection Sales by Country
    • 3.6.2 Latin America Ketorolac Injection Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Ketorolac Injection Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Ketorolac Injection Sales by Country
    • 3.7.2 Middle East and Africa Ketorolac Injection Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Ketorolac Injection Historic Market Analysis by Type

  • 4.1 Global Ketorolac Injection Sales Market Share by Type (2016-2021)
  • 4.2 Global Ketorolac Injection Revenue Market Share by Type (2016-2021)
  • 4.3 Global Ketorolac Injection Price by Type (2016-2021)

5 Global Ketorolac Injection Historic Market Analysis by Application

  • 5.1 Global Ketorolac Injection Sales Market Share by Application (2016-2021)
  • 5.2 Global Ketorolac Injection Revenue Market Share by Application (2016-2021)
  • 5.3 Global Ketorolac Injection Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Almaject
    • 6.1.1 Almaject Corporation Information
    • 6.1.2 Almaject Description and Business Overview
    • 6.1.3 Almaject Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Almaject Product Portfolio
    • 6.1.5 Almaject Recent Developments/Updates
  • 6.2 Amphastar
    • 6.2.1 Amphastar Corporation Information
    • 6.2.2 Amphastar Description and Business Overview
    • 6.2.3 Amphastar Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Amphastar Product Portfolio
    • 6.2.5 Amphastar Recent Developments/Updates
  • 6.3 Fresenius Kabi
    • 6.3.1 Fresenius Kabi Corporation Information
    • 6.3.2 Fresenius Kabi Description and Business Overview
    • 6.3.3 Fresenius Kabi Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Fresenius Kabi Product Portfolio
    • 6.3.5 Fresenius Kabi Recent Developments/Updates
  • 6.4 Hikma
    • 6.4.1 Hikma Corporation Information
    • 6.4.2 Hikma Description and Business Overview
    • 6.4.3 Hikma Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Hikma Product Portfolio
    • 6.4.5 Hikma Recent Developments/Updates
  • 6.5 Pfizer
    • 6.5.1 Pfizer Corporation Information
    • 6.5.2 Pfizer Description and Business Overview
    • 6.5.3 Pfizer Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Pfizer Product Portfolio
    • 6.5.5 Pfizer Recent Developments/Updates
  • 6.6 Sagent
    • 6.6.1 Sagent Corporation Information
    • 6.6.2 Sagent Description and Business Overview
    • 6.6.3 Sagent Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Sagent Product Portfolio
    • 6.6.5 Sagent Recent Developments/Updates
  • 6.7 Alvogen
    • 6.6.1 Alvogen Corporation Information
    • 6.6.2 Alvogen Description and Business Overview
    • 6.6.3 Alvogen Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Alvogen Product Portfolio
    • 6.7.5 Alvogen Recent Developments/Updates
  • 6.8 Athenex
    • 6.8.1 Athenex Corporation Information
    • 6.8.2 Athenex Description and Business Overview
    • 6.8.3 Athenex Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Athenex Product Portfolio
    • 6.8.5 Athenex Recent Developments/Updates
  • 6.9 BD RX
    • 6.9.1 BD RX Corporation Information
    • 6.9.2 BD RX Description and Business Overview
    • 6.9.3 BD RX Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 BD RX Product Portfolio
    • 6.9.5 BD RX Recent Developments/Updates
  • 6.10 Fosun Pharma
    • 6.10.1 Fosun Pharma Corporation Information
    • 6.10.2 Fosun Pharma Description and Business Overview
    • 6.10.3 Fosun Pharma Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Fosun Pharma Product Portfolio
    • 6.10.5 Fosun Pharma Recent Developments/Updates
  • 6.11 Virtus Pharmaceuticals
    • 6.11.1 Virtus Pharmaceuticals Corporation Information
    • 6.11.2 Virtus Pharmaceuticals Ketorolac Injection Description and Business Overview
    • 6.11.3 Virtus Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Virtus Pharmaceuticals Product Portfolio
    • 6.11.5 Virtus Pharmaceuticals Recent Developments/Updates

7 Ketorolac Injection Manufacturing Cost Analysis

  • 7.1 Ketorolac Injection Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Ketorolac Injection
  • 7.4 Ketorolac Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Ketorolac Injection Distributors List
  • 8.3 Ketorolac Injection Customers

9 Ketorolac Injection Market Dynamics

  • 9.1 Ketorolac Injection Industry Trends
  • 9.2 Ketorolac Injection Growth Drivers
  • 9.3 Ketorolac Injection Market Challenges
  • 9.4 Ketorolac Injection Market Restraints

10 Global Market Forecast

  • 10.1 Ketorolac Injection Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Ketorolac Injection by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Ketorolac Injection by Type (2022-2027)
  • 10.2 Ketorolac Injection Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Ketorolac Injection by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Ketorolac Injection by Application (2022-2027)
  • 10.3 Ketorolac Injection Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Ketorolac Injection by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Ketorolac Injection by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    15mg/ml
    30mg/ml

    Segment by Application
    Hospital
    Clinics
    Recovery Center

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Almaject
    Amphastar
    Fresenius Kabi
    Hikma
    Pfizer
    Sagent
    Alvogen
    Athenex
    BD RX
    Fosun Pharma
    Virtus Pharmaceuticals

    Buy now